908 Devices Inc. (MASS)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates
908 Devices NASDAQ: MASS outlined its strategy to expand in handheld chemical detection following second-quarter 2026 results that showed revenue growth, a narrower adjusted EBITDA loss and increasing recurring revenue.
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection
908 Devices outlined its strategy to focus exclusively on handheld chemical and drug detection technologies for public safety and defense markets, following the divestiture of its life-sciences business line about 15 months ago.
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market
908 Devices NASDAQ: MASS is sharpening its focus on handheld chemical and drug detection systems for public safety, defense and law enforcement following the divestiture of its bioprocessing and biopharma business line, executives said during a Canaccord Genuity discussion.
908 Devices Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Robert Bruce Robert Jeffrey Bruce is VP/Secretary at Bruce & Co Inc. | 68,286 | $520,339 | $683,542.86 | $163,203.86 | 31.36% |
 Joseph Castro Nuveen LLC | 141,727 | $808,274.47 | $1.25M | $438,923.13 | 54.3% |
| WM Wesley McDowell Meros Investment Management LP | 361,368 | $2.16M | $3.62M | $1.46M | 67.3% |
 Taro Kuriyama Axq Capita LLP | 10,704 | $93,125 | $90,448.8 | -$2,676.2 | -2.87% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 3 | $18 | $25.35 | $7.35 | 40.83% |
908 Devices Inc. (MASS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has 908 Devices Inc. ever had a stock split?
908 Devices Inc. Profile
| Technology Hardware, Storage & Peripherals Industry | Information Technology Sector | Kevin J. Knopp CEO | NASDAQ (NMS) Exchange | 65443P102 CUSIP |
| US Country | 172 Employees | - Last Dividend | - Last Split | 18 Dec 2020 IPO Date |
Overview
908 Devices Inc. is a commercial-stage technology company that specializes in providing handheld and desktop mass spectrometry devices designed for a broad range of applications. The company focuses on developing tools for the analysis of unknown and invisible materials across various sectors, including life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Established in 2012 and headquartered in Boston, Massachusetts, 908 Devices offers its cutting-edge analytical tools to customers not only in the United States but also in Europe, the Middle East, Africa, the Asia Pacific, and the rest of the Americas.
Products and Services
-
MX908:
This product is a portable, battery-powered mass spectrometry (Mass Spec) device designed for the swift analysis of solid, liquid, vapor, and aerosol materials. Its handheld form factor makes it especially useful in environments where rapid, on-the-spot analysis of unknown substances is critical.
-
Rebel:
Rebel serves as a compact desktop analyzer that delivers real-time insights into the extracellular environment of bioprocesses. It’s engineered for users who need to monitor the biochemical and physical properties of cell culture media in bioprocessing applications.
-
Maverick:
This optical in-line analyzer is aimed at real-time monitoring and control of multiple parameters in mammalian cell cultures, such as glucose, lactate, and total biomass. Maverick also provides process fingerprint data, which can be instrumental in supporting predictive bioprocess modeling on a large scale.
-
Maven and Trace C2:
An online device designed for bioprocess monitoring and control, catering to the needs of bioengineering professionals requiring accurate, real-time data to ensure the optimal conditions of their bioprocesses.
-
ZipChip:
ZipChip is an innovative, plug-and-play, high-resolution separation platform that enhances Mass Spec sample analysis efficiency. It’s intended for users seeking to optimize their mass spectrometry workflows with a high-throughput, easy-to-integrate solution.
